Tapentadol prolonged release for severe chronic cancer-related pain: effectiveness, tolerability, and influence on quality of life of the patients

BACKGROUND: Clinical trials have shown the efficacy and good tolerability of tapentadol prolonged release (PR) for severe chronic pain of different etiologies. This study investigated the influence of tapentadol PR on pain control and quality of life of patients with severe chronic cancer-related pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Schikowski, Artur, Krings, Doris, Schwenke, Karla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278778/
https://www.ncbi.nlm.nih.gov/pubmed/25565884
http://dx.doi.org/10.2147/JPR.S72150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278778/
https://www.ncbi.nlm.nih.gov/pubmed/25565884
http://dx.doi.org/10.2147/JPR.S72150

Ejemplares similares